Results per Page:
Could fecal microbiota transplantation help patients heal after stem cell transplantation?
Phase 2 clinical trial shows a safe dose from a specific donor helped with gut microbiome recovery in people with cancer
Sequencing gut bacterial genes to improve colorectal cancer detection
From the Dey Lab, Translational Sciences and Therapeutics Division
Understanding how microbial imbalances may influence Juvenile Dermatomyositis, a rare immune-mediated disease
From the Dey Lab, Pathogen Associated Malignancies Program of the Cancer Consortium
Gut microbes dictate donor T cell expansion and graft-versus-host disease risk after stem cell transplantation
From the Hill Lab, Translational Science and Therapeutics Division
Microbial cell-free DNA may help predict transplantation outcomes
From the Markey Lab, Translational Science and Therapeutics Division
Pre-transplant microbiome sets the stage for GVHD
Preclinical findings highlight bacterial groups that influence GVHD risk
Associations of the gut microbiome and hepatic adiposity
From the Johanna Lampe Group
Shed the pandemic pounds ... and the stupor
As vaccines roll out and the crisis ebbs, get more sleep, eat mostly plants, keep moving and stay connected
Studying how maternal immune factors shape infant health
Immunologist Dr. Megan Koch named 2020 Pew Scholar in the Biomedical Sciences
Two Irish microbiologists find their way, together, to Seattle
Microbiome experts Drs. Susan Bullman and Christopher Johnston join Fred Hutch
Infections in immune-compromised patients: 5 new frontiers
Infectious disease experts gather in Seattle to find solutions for patients with compromised immunity
Fred Hutch deepens its focus on the microbiome
Microbiome Research Initiative hosts 2-day symposium
Jump-starting innovative projects exploring pathogen-associated cancers
Pathogen-Associated Malignancies Integrated Research Center awards first round of pilot funding supporting researchers studying H. pylori, EBV and the microbiome
Enlisting the microbiome in the quest for an AIDS vaccine
We now know that microbial communities, especially in our guts, profoundly affect immune response